semaglutide vs dulaglutide tops when treating patients with type 2 diabetes and CVD A trial emulation in Nature

Researchers used mouse models that let them focus on and study specific biological processes

Injection site reactions are among the most frequently reported adverse effects associated with subcutaneous medicines, including those in the GLP-1 receptor agonist class

Spears combines emergency medicine expertise with clinical research experience to deliver evidence-based GLP-1 care you can trust

IGF-1 LR3: Long-acting, systemic effects (2030 hours)

Your small intestine releases proteolytic enzymes, including trypsin, chymotrypsin, and carboxypeptidase, that systematically cleave peptide bonds into individual amino acids for absorption